Your search history is turned on.
Date: April 2, 2024 Jurisdictions: Alberta, British Columbia, Ontario
Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate I, Ralph Proceviat, Chief Financial Officer of Izotropic Corporation, certify the following: 1. Review: I have reviewed the Interim Financial Report and Interim MD&A (together, the Interim Filings) of Izotropic Corporation (the Issuer) for the interim period ended January 31,...
Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate I, Robert Thast, Chief Executive Officer of Izotropic Corporation, certify the following: 1. Review: I have reviewed the Interim Financial Report and Interim MD&A (together, the Interim Filings) of Izotropic Corporation (the Issuer) for the interim period ended January 31, 20...
MANAGEMENTS DISCUSSION AND ANALYSIS Three and Nine months ended January 31, 2024 and 2023 (In Canadian dollars) Izotropic Corporation Page 2 MD&A Three and nine months ended January 31, 2024 Management's Discussion & Analysis This Managements Discussion and Analysis (the MD&A...
Condensed Interim Consolidated Financial Statements (Unaudited) For the three and nine months ended January 31, 2024 and 2023 (In Canadian dollars) NOTICE OF NO AUDITOR REVIEW OF UNAUDITED CONDENSED INTERIM CONSOLIDATED FINA...
Date: January 30, 2024 Jurisdictions: Alberta, British Columbia, Ontario
Izotropic Receives Response From U.S. FDA Vancouver, British Columbia--(Newsfile Corp. - January 30, 2024) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a medical device company commercializing IzoView, a CT (computed tomography) imaging system, that produces images of anatomy for non-invasive characterization of tissue with an application in breast i...
Date: January 8, 2024 Jurisdictions: Alberta, British Columbia, Ontario
[email protected] www.izocorp.com #424, 800-15355 24th Ave. Surrey, BC V4A 2H9 NEWS RELEASE IZOTROPIC PROVIDES REGULATORY AND OPERATIONAL UPDATES VANCOUVER, BC, January 8, 2024 Izotropic Corporation (Izotropic or the Company) (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3), a medical device company commercializing IzoView, a CT (computed tomography...
Date: December 31, 2023 Jurisdictions: Alberta, British Columbia, Ontario
Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate I, Ralph Proceviat, Chief Financial Officer of Izotropic Corporation, certify the following: 1. Review: I have reviewed the Interim Financial Report and Interim MD&A (together, the Interim Filings) of Izotropic Corporation (the Issuer) for the interim period ended October 31,...
Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate I, Robert Thast, Chief Executive Officer of Izotropic Corporation, certify the following: 1. Review: I have reviewed the Interim Financial Report and Interim MD&A (together, the Interim Filings) of Izotropic Corporation (the Issuer) for the interim period ended October 31, 20...
MANAGEMENTS DISCUSSION AND ANALYSIS Three and six months ended October 31, 2023 (In Canadian dollars) Izotropic Corporation Page 2 MD&A Three and six months ended October 31, 2023 Management's Discussion & Analysis This Managements Discussion and Analysis (the MD&A) of th...
Condensed Interim Consolidated Financial Statements (Unaudited) For the three and six months ended October 31, 2023 and 2022 (In Canadian dollars) NOTICE OF NO AUDITOR REVIEW OF UNAUDITED CONDENSED INTERIM CONSOLIDATED FINANCIAL STATMENTS...